Gary E. Stein
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 42
- Antibiotics Pharmacokinetics and Efficacy 40
- Epidemiology 35
- Pneumonia and Respiratory Infections 15
- Urinary Tract Infections Management 12
- Co-authors
- Louis D. Saravolatz (5 shared papers)Leonard B. Johnson (2 shared papers)Timothy Babinchak (1 shared paper)Daniel Havlichek (16 shared papers)Elizabeth Wells (1 shared paper)David P. Nicolau (8 shared papers)Robert D. Walker (4 shared papers)E. J. C. Goldstein (1 shared paper)
- Journals
- Clinical Infectious Diseases (11 papers)Annals of Pharmacotherapy (8 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (7 papers)Antimicrobial Agents and Chemotherapy (5 papers)Diagnostic Microbiology and Infectious Disease (4 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Gary E. Stein
83 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 125
- Molecular Medicine 718
- Applied Microbiology and Biotechnology 132
- Clinical Biochemistry 353
- Pharmacology 834
- Microbiology 295
Countries citing papers authored by Gary E. Stein
This map shows the geographic impact of Gary E. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Stein more than expected).
Fields of papers citing papers by Gary E. Stein
This network shows the impact of papers produced by Gary E. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Stein. The network helps show where Gary E. Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 238 | |
| 2 | 1987 | 160 | |
| 3 | 2013 | 155 | |
| 4 | 2011 | 140 | |
| 5 | 1995 | 119 | |
| 6 | 1996 | 109 | |
| 7 | 2010 | 108 | |
| 8 | 2009 | 102 | |
| 9 | 1999 | 101 | |
| 10 | 2012 | 85 | |
| 11 | 2005 | 69 | |
| 12 | 2015 | 68 | |
| 13 | 1992 | 67 | |
| 14 | 2006 | 64 | |
| 15 | 2007 | 59 | |
| 16 | 2019 | 58 | |
| 17 | 1987 | 58 | |
| 18 | 1995 | 47 | |
| 19 | 2018 | 44 | |
| 20 | 1993 | 44 |
About Gary E. Stein
Gary E. Stein is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Medicine and Clinical Biochemistry, having authored 84 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (40 papers), Antimicrobial Resistance in Staphylococcus (23 papers), Antibiotic Resistance in Bacteria (19 papers), Bacterial Identification and Susceptibility Testing (16 papers), Pneumonia and Respiratory Infections (15 papers), Urinary Tract Infections Management (12 papers), Reproductive tract infections research (8 papers) and Antifungal resistance and susceptibility (5 papers). The work is most often cited by research in Molecular Medicine (718 citations), Applied Microbiology and Biotechnology (132 citations), Clinical Biochemistry (353 citations), Pharmacology (834 citations) and Microbiology (295 citations). Gary E. Stein has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Louis D. Saravolatz, Leonard B. Johnson, Timothy Babinchak, Daniel Havlichek, Elizabeth Wells, David P. Nicolau, Robert D. Walker, E. J. C. Goldstein, Thomas M. File and Mark H. Wilcox. Their work appears in journals such as Clinical Infectious Diseases, Annals of Pharmacotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Antimicrobial Agents and Chemotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.